Engineered immune cells may be able to tame inflammation
Immune cells that are designed to soothe inflammation could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions. …
Immune cells that are designed to soothe inflammation could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions. …
Drugs that suppress the UBA1 enzyme could make immune checkpoint blocking immunotherapy effective for patients with prostate cancer and other cold tumors. …
A new study finds that exposure to fine particulate matter (PM2.5) air pollution during pregnancy is associated with altered immune responses that can lead to adverse birth outcomes. …
Aging specifically impairs the generation of CD8+ tissue-resident memory T cells and thus compromises antitumor immunity. …
A new study reveals how electrical stimulation of the vagus nerve—a major nerve connecting the brain and gut—may help reduce the stress-related inflammation that worsens inflammatory bowel disease symptoms. …
New research in mice uncovers how inhaled house dust mites, a common trigger of allergic asthma, activate the immune system and drive this disease. …
A new drug strategy that regulates the tumor immune microenvironment may make resistant pancreatic cancer tumors responsive to immunotherapy. …
Scientists employed epigenetic therapy to induce glioblastoma cells to express immune system targets, thereby potentially rendering them visible to immune cells and increasing their susceptibility to immunotherapies. …
Cancer immunotherapy-associated heart inflammation is driven by an immune response distinct from the anti-tumor response, indicating that this serious complication might be managed without stopping cancer therapy. …
A study in mice found that immune-stimulating protein fragments, called guardian peptides, are produced by the brain and spinal cord to maintain the brain’s immune balance, allowing for healthy communication with the immune system. …
End of content
End of content